| Product Code: ETC12651929 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Leishmaniasis Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Leishmaniasis Market - Industry Life Cycle |
3.4 Mexico Leishmaniasis Market - Porter's Five Forces |
3.5 Mexico Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Mexico Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 Mexico Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Mexico Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mexico Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 Mexico Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about leishmaniasis among the population |
4.2.2 Government initiatives to control and prevent the spread of leishmaniasis |
4.2.3 Rising incidence of leishmaniasis cases in Mexico |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 Challenges in accurate diagnosis of leishmaniasis |
4.3.3 High cost of treatment and medications for leishmaniasis patients |
5 Mexico Leishmaniasis Market Trends |
6 Mexico Leishmaniasis Market, By Types |
6.1 Mexico Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 Mexico Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 Mexico Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 Mexico Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 Mexico Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 Mexico Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 Mexico Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 Mexico Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 Mexico Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 Mexico Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 Mexico Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 Mexico Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 Mexico Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Mexico Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 Mexico Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 Mexico Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 Mexico Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 Mexico Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 Mexico Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Mexico Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Mexico Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Mexico Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 Mexico Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 Mexico Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 Mexico Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 Mexico Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 Mexico Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 Mexico Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 Mexico Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 Mexico Leishmaniasis Market Import-Export Trade Statistics |
7.1 Mexico Leishmaniasis Market Export to Major Countries |
7.2 Mexico Leishmaniasis Market Imports from Major Countries |
8 Mexico Leishmaniasis Market Key Performance Indicators |
8.1 Percentage of population receiving leishmaniasis education and awareness programs |
8.2 Number of government-funded projects focused on leishmaniasis prevention and control |
8.3 Incidence rate of leishmaniasis cases in Mexico |
8.4 Percentage of leishmaniasis cases diagnosed accurately and promptly |
8.5 Affordability and accessibility index of leishmaniasis treatments |
9 Mexico Leishmaniasis Market - Opportunity Assessment |
9.1 Mexico Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Mexico Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 Mexico Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Mexico Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mexico Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 Mexico Leishmaniasis Market - Competitive Landscape |
10.1 Mexico Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 Mexico Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here